Value Proposition Concept for a Medical Device - Pilot Study STERLINK (Plasma Sterilizer)

被引:0
|
作者
Hospodkova, Petra [1 ]
Horejsi, Jolana [1 ]
Friebova, Eliska [1 ]
Maskova, Barbora [1 ]
Rogalewicz, Vladimir [1 ]
机构
[1] Czech Tech Univ, Fac Biomed Engn, Dept Biomed Technol, Kladno 27201, Czech Republic
关键词
HTA; Product Value; Proposition; TCO; Qualitative Research; Plasma Sterilizer; Market Penetration; GAS PLASMA; CZECH;
D O I
10.1007/978-3-031-62520-6_1
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
This case study assesses the Sterlink plasma sterilizer's value proposition in the Czech healthcare market, considering economic, user, and clinical perspectives. The economic analysis includes TCO calculations, the user value is determined through interviews analyzed using MAQXDA 2022 software, while the clinical value is derived from a synthesis of clinical benefits and risks. Findings reveal consumables cost as the primary ownership expense, with Sterlink's strengths being speed, gentleness, and compactness. Interviews highlight advantages such as gentleness, rapid plasma sterilization, user-friendliness, and easy installation, alongside drawbacks of acquisition and consumable cost and regulatory compliance. This research proposes a universal approach, aiding medical device manufacturers in deeper market penetration, and a formulation of appropriate communication strategies targeting opinion leaders and decision-makers. Recommendations include precise pricing communication based on product value, and tailored communication for various buyer categories. Expanding into dentistry, clinical laboratories, and the microsurgical field is suggested for market entry. This research recommends market strategies and underscores the importance of understanding the medical device multifaceted healthcare value proposition.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 50 条
  • [41] New medical device coating mouth gel for temporary relief of teething symptoms: a pilot randomized, open-label, controlled study
    Rosu, Serban
    Barattini, Dionisio F.
    Murina, Filippo
    Gafencu, Mihai
    MINERVA PEDIATRICS, 2023, 75 (04): : 514 - 527
  • [42] EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
    Satapathy, Shraddhanjali
    Singh, Varsha
    Nambirajan, Aruna
    Malik, Prabhat Singh
    Tanwar, Pranay
    Mehta, Anurag
    Suryavanshi, Moushumi
    Thulkar, Sanjay
    Mohan, Anant
    Jain, Deepali
    CURRENT PROBLEMS IN CANCER, 2021, 45 (06)
  • [43] Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot study
    Sliwinski, Svenja
    Faqar-Uz-Zaman, Sara Fatima
    Heil, Jan
    Mohr, Lisa
    Detemble, Charlotte
    Dreilich, Julia
    Zmuc, Dora
    Bechstein, Wolf O.
    Becker, Sven
    Chun, Felix
    Derwich, Wojciech
    Schreiner, Waldemar
    Solbach, Christine
    Fleckenstein, Johannes
    Filmann, Natalie
    Schnitzbauer, Andreas A.
    PATIENT SAFETY IN SURGERY, 2024, 18 (01)
  • [44] Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers - a randomized pilot study
    Romanelli, Marco
    Macchia, Michela
    Panduri, Salvatore
    Paggi, Battistino
    Saponati, Giorgio
    Dini, Valentina
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2787 - 2792
  • [45] Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study
    Nicola Alessandro Iacovelli
    Simona Naimo
    Francesca Bonfantini
    Anna Cavallo
    Paolo Bossi
    Carlo Fallai
    Emanuele Pignoli
    Salvatore Alfieri
    Cristiana Bergamini
    Federica Favales
    Ester Orlandi
    Supportive Care in Cancer, 2017, 25 : 1787 - 1795
  • [46] Preemptive treatment with XonridA®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study
    Iacovelli, Nicola Alessandro
    Naimo, Simona
    Bonfantini, Francesca
    Cavallo, Anna
    Bossi, Paolo
    Fallai, Carlo
    Pignoli, Emanuele
    Alfieri, Salvatore
    Bergamini, Cristiana
    Favales, Federica
    Orlandi, Ester
    SUPPORTIVE CARE IN CANCER, 2017, 25 (06) : 1787 - 1795
  • [47] A pilot study of the predictive value of plasma tumor necrosis factor alpha and interleukin 1 beta for Streptococcus pneumoniae bacteremia in febrile children
    Strait, RT
    Ruddy, RM
    Friedland, LR
    Duncan, KM
    Wilmott, RW
    ACADEMIC EMERGENCY MEDICINE, 1997, 4 (01) : 44 - 51
  • [48] Protocol for a usability and pilot implementation study of a digital medical device to assess pain in non-verbal people with dementia in Portuguese residential care facilities
    Guerreiro, Mara Pereira
    Felix, Isa Brito
    Tome, Morgane
    Hoti, Kreshnik
    Ramos, Catarina
    Dias, Beatriz
    Andrade, Teresa
    Brito, Jose
    Hughes, Jeff
    DIGITAL HEALTH, 2025, 11
  • [49] Validation of a novel medical device (Chloe SED®) for the administration of analgesia during manual vacuum aspiration: a randomized controlled non-inferiority pilot study
    Ramanathan, Aparna
    Samenjo, Karlheinz Tondo
    Bailey, Robert C.
    Imbamba, Javan
    Odenyo, Stella
    Koksal, Erin
    Diehl, Jan Carel
    Omoto, Jackton
    Gwer, Stephen
    FRONTIERS IN PAIN RESEARCH, 2024, 5
  • [50] Predictive Value of Baseline Plasma D-dimers for Chemotherapy-induced Thrombocytopenia in Patients with Stage III Colon Cancer: A Pilot Study
    Tanriverdi, Ozgur
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (01) : 293 - 297